Cargando…
Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy
A better understanding of mechanistic insights into genes and enzymes implicated in rare diseases provide a unique opportunity for orphan drug development. Advances made in identification of synthetic lethal relationships between rare disorder genes with oncogenes and tumor suppressor genes have bro...
Autores principales: | Bhattacharjee, Sonali, Nandi, Saikat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162646/ https://www.ncbi.nlm.nih.gov/pubmed/30200453 http://dx.doi.org/10.3390/cancers10090298 |
Ejemplares similares
-
DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway
por: Bhattacharjee, Sonali, et al.
Publicado: (2017) -
Choices have consequences: the nexus between DNA repair pathways and genomic instability in cancer
por: Bhattacharjee, Sonali, et al.
Publicado: (2016) -
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
por: Ghosh, Debarati, et al.
Publicado: (2018) -
Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2020) -
DNA repair defects in cancer and therapeutic opportunities
por: Hopkins, Jessica L., et al.
Publicado: (2022)